logo of the vendor
Pharma Intelligence UK Ltd logo

Incorporating Digital Biomarkers & Endpoints Into Clinical Trials: Key Regulatory Considerations

thumbnail of content

As technology advances and innovations like digital endpoints and biomarkers become more prevalent, regulatory considerations surrounding them become more complex. Navigate this evolving space, with insights from this free webinar.

Experts from Biofourmis will share their insights into:

  • Traditional vs. digital measures in clinical research and their key differences.
  • Regulatory framework for digital biomarkers and endpoints, including regional disparities.
  • Regulatory considerations for data integrity and security, validation and reliability, and patient safety and privacy.
  • Integrating digital biomarkers and endpoints into trial protocols.
  • Emerging and current regulatory trends and future regulatory direction.


Register for the Webinar

Opt In?

Explore similar content

Delta logo
Europa Science (Electro Optics) logo
thumbnail of the content

Custom vs. Catalogue Optical Filters: Benefits for Instrument Makers

The in-depth analysis shows how custom optical filters outperform standard catalogue options in boosting the performance of scientific and industrial instruments like fluorescence microscopes and spectrophotometers. It explains how tailored filters are designed to meet specific performance requirements, ensuring greater accuracy, reliability, and cost-efficiency. Unlike catalogue filters, custom solutions allow manufacturers to optimize critical parameters such as wavelength range, out-of-band blocking, and physical dimensions, which enhances instrument functionality while reducing complexity. The paper also highlights how custom filters can improve integration, streamline design, and deliver cost-effective solutions, ultimately providing a competitive advantage in specialized applications across various industries.
Whitepaper Research and Development
Icon logo
Pharma Intelligence UK Ltd logo
thumbnail of the content

Resiliency and innovation - Navigating the current biotech landscape

Gain insight from ICON’s Biotech President, Chris Smyth, on the biggest barriers to success in biotech, and the key strategies required to survive and thrive in this dynamic and competitive landscape. Download the article to gain perspective on the:
Article Clinical Studies Pharmaceutical Research and Development
Novotech logo
Pharma Intelligence UK Ltd logo
thumbnail of the content

HIV – Global Clinical Trial Landscape

Explore the far-reaching impact of HIV, the latest global research priorities, and the innovative treatments, such as Antiretroviral therapy (ART), that offer hope in finding a cure. Gain insights from CRO experts, Novotech, on key topics, such as:
Report Clinical Studies Pharmaceutical Research and Development